ORLANDO BAUTISTA: Open Payments
NPI 1386695492 · HAUPPAUGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 25 payments from 15 companies in 2025. Trend: 2023 $2,391 · 2024 $375 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Lilly USA, LLC | 3 | $69 |
| Astellas Pharma US Inc | 2 | $51 |
| Ardelyx, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $21 |
Products named: Veozah, IBSRELA, UBRELVY, XIFAXAN, JARDIANCE, ZEPBOUND, JOURNAVX, GEMTESA.
Industry payments across NY — which companies pay providers there.
